Suven Pharmaceuticals

quarterly
yearly
ParticularsJun '23Sep '23Dec '23Mar '24Jun '24
Revenue354.09238.82226.80260.39240.04
Expenses186.44138.25157.29189.33152.65
EBITDA179.94111.5583.0389.00100.99
EBIT168.80101.0771.6473.3588.99
Profit Before Tax167.64100.5769.5071.0587.39
Net Profit124.2974.7352.3653.4365.08
Financial Ratios
Operating Profit Margin52.30%49.66%39.01%36.55%45.47%
Net Profit Margin36.13%33.27%24.60%21.94%29.30%
Earning Per Share (Diluted)4.882.942.062.102.56
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.4.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ